News Details

CPD: Announces FDA Approval to Market Generic Glucotrol(R) [delayed]

2006/07/12 12:01:38

Ridgeland, MS, JUL 12, 2006 (EventX/Knobias.com via COMTEX) -- Caraco Pharmaceutical Laboratories, Ltd. (CPD) announced that the FDA has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Glipizide tablets. Caraco's Glipizide tablets are the generic equivalent of Pfizer's Glucotrol(R), an anti-diabetic drug, which is indicated as an adjunct to diet for the control of hyperglycemia and the associated symptomatology in patients with non-insulin-dependent diabetes mellitus, (NIDDM), Type-2 diabetes. Caraco Pharma will manufacture and market both 5mg and 10mg tablets.  GET KNOBIAS IN REAL-TIME: Delivery of this proprietary Knobias alert has been delayed by at least 10 minutes. To get all Knobias alerts in real-time daily, visit http://www.knobias.com/cmtx  ABOUT KNOBIAS: Knobias is a premier financial information provider of trading and investing data covering all U.S. equities for investors and security professionals. Knobias is best described by its three major components: Real-time desktop applications providing quotes, charts, level 2, analysis etc.; Knobias RAiDAR providing thousands of real-time news stories, alerts and documents daily; Knobias fundamentals providing a comprehensive database of fundamental research information.  CONTACT: Knobias.com, LLC  601-978-3399  601-978-3675  info@knobias.com   www.knobias.com/cmtx  Copyright 2004 Knobias.com, LLC, All rights reserved.  **********************************************************************  As of Saturday, 07-08-2006 23:59, the latest Comtex SmarTrend(SM) Alert, an automated pattern recognition system, indicated a DOWNTREND on 05-19-2006 for CPD @ $11.48.  For more information on Comtex SmarTrend? Alert, contact your market data provider or go to CSTADirect.com  SmarTrend is a registered trademark of Comtex News Network, Inc. Copyright ? 2004-2006 Comtex News Network, Inc. All rights reserved.  -0-  SUBJECT CODE: FDA/R&D  Watch Stories  KNO-Zone  Important Co. News  Mover  MOVER(+)  12-Jul-2006 12:01